- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 37.26M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $928.7M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $927.3M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $300K |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $200K |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $8.1M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $16.9M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $306.5M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $296.2M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $984M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $929.8M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.28B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.27B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.63B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.61B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.73B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.67B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $3.63B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $3.54B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 37.6M sh |
| Stock Repurchased restated | Q1 2025 · Mar 31, 2024 | $0 |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$23.5M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.39 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.39 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $161.6M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $24.2M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$14.6M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $23.8M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $208.6M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $686.8M |
| Revenue | Q1 2025 · Mar 31, 2024 | $895.4M |
| Revenue | Q1 2025 · Sep 30, 2023 | $895.4M |